Rock Springs Capital Management LP Q1 2017 Filing
Filed May 15, 2017
Portfolio Value
$1.7B
Holdings
140
Report Date
Q1 2017
Filing Type
13F-HR
All Holdings (140 positions)
| Stock | Value |
|---|---|
—CARDIOME PHARMA CORP | $3.6M |
CGENCOMPUGEN LTD | $3.5M |
—PROTEOSTASIS THERAPEUTICS IN | $3.5M |
PBYIPUMA BIOTECHNOLOGY INC | $3.5M |
MDGLMADRIGAL PHARMACEUTICALS INC | $3.5M |
RIGLUSDRIGEL PHARMACEUTICALS INC | $3.3M |
INVAINNOVIVA INC | $3.3M |
GKOSGLAUKOS CORP | $3.2M |
HRCHILL ROM HLDGS INC | $3.2M |
ITCIEURINTRA CELLULAR THERAPIES INC | $3.1M |
—GENOCEA BIOSCIENCES INC | $2.9M |
—BLUEBIRD BIO INC | $2.8M |
CARAEURCARA THERAPEUTICS INC | $2.8M |
ZBHZIMMER BIOMET HLDGS INC | $2.6M |
OTICEUROTONOMY INC | $2.6M |
—DBV TECHNOLOGIES S A | $2.6M |
MCRB1EURSERES THERAPEUTICS INC | $2.5M |
—CIDARA THERAPEUTICS INC | $2.3M |
—NEURODERM LTD | $2.2M |
HQYHEALTHEQUITY INC | $2.1M |
SCYXEURSCYNEXIS INC | $2.1M |
—THERAVANCE BIOPHARMA INC | $1.9M |
—MYOVANT SCIENCES LTD | $1.8M |
—NIVALIS THERAPEUTICS INC | $1.8M |
NVCRNOVOCURE LTD | $1.7M |
—ATYR PHARMA INC | $1.7M |
—NEWLINK GENETICS CORP | $1.6M |
—EGALET CORP | $1.5M |
—WRIGHT MED GROUP INC | $1.2M |
NVAXNOVAVAX INC | $1.1M |
PRGOPERRIGO CO PLC | $1.0M |
DVAXDYNAVAX TECHNOLOGIES CORP | $982K |
INFIQINFINITY PHARMACEUTICALS INC | $872K |
—CHIASMA INC | $837K |
BHCVALEANT PHARMACEUTICALS INTL | $732K |
—TANDEM DIABETES CARE INC | $714K |
—OREXIGEN THERAPEUTICS INC | $569K |
—ANTHERA PHARMACEUTICALS INC | $552K |
—CERULEAN PHARMA INC | $508K |
—DIMENSION THERAPEUTICS INC | $475K |
PreviousPage 2 of 2